MINNEAPOLIS, May 24, 2018 /PRNewswire/ -- Bio-Techne
Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive
Officer, will present at the Jefferies 2018 Healthcare Conference
on Tuesday, June 5, 2018, at
2:00 p.m. EDT. The conference will be
held at the Grand Hyatt New York in New
York City.
A live webcast of the presentation can be accessed via
Bio-Techne's Investor Relations website at
https://investors.bio-techne.com/ or through the following link
http://wsw.com/webcast/jeff113/tech/.
Bio-Techne Corporation (NASDAQ: TECH) is a leading
developer and manufacturer of high quality purified
proteins––notably cytokines and growth factors, antibodies,
immunoassays, as well as biologically active small molecule
compounds and ACD's in-situ hybridization detection products ---
which are sold to biomedical researchers and clinical research
laboratories; these operations constitute the core Biotech
Division, headquartered in Minneapolis,
Minnesota. The Protein Platform Division manufactures
innovative protein analysis tools under the ProteinSimple brand
name that greatly automate western blotting and immunoassay
practices. The Diagnostics Division manufactures FDA-regulated
controls, calibrators, blood gas and clinical chemistry controls
and other reagents for OEM customer and clinical customers.
Bio-Techne products are integral components of scientific
investigations into biological processes and the nature and
progress of specific diseases. They aid in drug discovery efforts
and provide the means for accurate clinical tests and diagnoses.
With thousands of products in its portfolio, Bio-Techne generated
approximately $563 million in net
sales in fiscal 2017 and has approximately 1,800 employees
worldwide. For more information on Bio-Techne and its brands,
please visit www.bio-techne.com.
Contact:
|
David Clair, Investor
Relations
|
|
ir@bio-techne.com
|
|
646-277-1266
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-jefferies-2018-healthcare-conference-300654129.html
SOURCE Bio-Techne Corporation